Recruiting Parkinsons Disease Studies in Englewood
To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications
This is a randomized, double-blind, placebo-controlled, multicenter study in participants with Parkinson's disease (PD) with motor fluctuations. Participants will be randomized to receive once-daily o...
A Study to Evaluate Solrikitug in Participants With COPD (ZION)
A Randomized, Double-blind, Placebo-controlled, Multiple Dose-Ranging Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Solrikitug in Participants with Chronic Obstru...
A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
The objective of this randomized, surgically controlled, double-blinded, Phase 2 study is to evaluate the safety and efficacy of AAV2-GDNF delivered to the putamen in subjects with moderate Parkinson'...
A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's Disease
The primary objectives of this study are to assess the efficacy of TB006 in improving motor function and to assess the safety of TB006 in participants with Parkinson's Disease (PD)....
A Phase 1b Study of the NLRP3 Inhibitor VENT-02 in Patients With Mild to Moderate Parkinson's Disease
This trial is a randomized, double-blind, placebo-controlled Phase 1b study evaluating the safety/tolerability, PK, and pharmacodynamics of VENT 02, administered orally at 1 dose level twice daily (BI...
Phase 1/2a Clinical Trial of PR001 (LY3884961) in Patients With Parkinson's Disease With at Least One GBA1 Mutation (PROPEL)
Study J3Z-MC-OJAA is a Phase 1/2a, multicenter, open-label, ascending dose, first in-human study that will evaluate the safety of intracisternal LY3884961 administration in patients with moderate to s...
About Parkinsons Disease Clinical Trials in Englewood
Parkinson's disease is a progressive nervous system disorder that affects movement, causing tremors, stiffness, and difficulty with balance. It results from the loss of dopamine-producing neurons in the brain. Treatment includes medications, deep brain stimulation, and emerging therapies targeting disease modification.
There are currently 6 parkinsons disease clinical trials recruiting participants in Englewood, COLORADO. These studies are seeking a combined 700 participants. Research is being sponsored by Cerevance, Uniquity One (UNI), AskBio Inc and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Parkinsons Disease Clinical Trials in Englewood — FAQ
Are there parkinsons disease clinical trials in Englewood?
Yes, there are 6 parkinsons disease clinical trials currently recruiting in Englewood, COLORADO. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Englewood?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Englewood research site will contact you about next steps.
Are clinical trials in Englewood free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Englewood studies also compensate for your time and travel.
What parkinsons disease treatments are being tested?
The 6 active trials in Englewood are testing new therapies including novel drugs, biologics, and treatment approaches for parkinsons disease.
Data updated March 2, 2026 from ClinicalTrials.gov